Ribon Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
35 Cambridgepark Dr, Cambridge, Massachu...Phone Number
(617) 914-8700Website
www.ribontx.comRevenue
$43.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Ribon Therapeutics
Ribon Therapeutics is a clinical stage biotechnology company developing therapeutics targeting novel enzyme families activated under cellular stress conditions that contribute to disease with the goal of developing effective treatments for patients with limited therapeutic options. Ribon Therapeutics is located in Cambridge, Massachusetts.Explore more
Ribon Therapeutics Org Chart
MR
Vice President, Clinical Operations
IV
Global Vice President, Regulatory Affairs
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ribon Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Ribon Therapeutics has new funding data
Earning: See what the market has to say on Ribon Therapeutics recently announced quarterly report
Product Launch: Get notified when Ribon Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Ribon Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Ribon Therapeutics
Check if Ribon Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Ribon Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Ribon Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Ribon Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Ribon Therapeutics
Compare insights from companies similar to Ribon Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ribon Therapeutics
$43.5M
11-50
Private
$251.5M
2015
AR
Amilcar RibeiroVice President, Clinical Operations
Company Profile Activity
Activity Insights
Ribon Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ribon Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ribon Therapeutics.
Ribon Therapeutics financials insights
Gather financial insights about Ribon Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Multiple Rounds
$76.5M
2017
Private Equity
$20M
2019
Series B
$65M
2021
Unspecified
$65M
2023
Private Equity
$25M
Ribon Therapeutics Tech Stack
A closer look at the technologies used by Ribon Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Move
Board of Directors
Funding
Open Position
Ribon Therapeutics News & Media
Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ribon Therapeutics, a clinical-stage biotechnology company developing therapeutics to target stress support pathways, today announced a $25 million investment from Pfizer. Ribon plans to use the proceeds to support clinical development of its potentially first-in-class oral small molecule programs in oncology (RBN-2397, a PARP7 inhibitor) and immunology (RBN-3143, a PARP14 inhibitor). As part of the investment, Robert Rickert, Ph.D., Senior Vice President andRibon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim
Ribon Therapeutics, a clinical stage biotechnology company developing therapeutics targeting stress support pathways, today announced that it enteredRibon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ribon Therapeutics, a clinical stage biotechnology company developing therapeutics targeting stress support pathways, today announced that it entered into an agreement on the acquisition of its CD38 program with Boehringer Ingelheim. This includes a small molecule inhibitor designed to modulate intra- and extracellular CD38 activity, potentially restoring immune function in various diseases, as well as corresponding patents and other proprietary information. BRibon Therapeutics Announces Late-Breaking Presentation of Preclinical Data on RBN-3143 at the European Respiratory Society International Congress 2022
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ribon Therapeutics, a clinical stage biotechnology company developing therapeutics targeting stress support pathways, today announced in a late-breaking presentation, compelling preclinical data for RBN-3143, a novel, orally administered, first-in-class inhibitor of PARP14 with potential in a range of inflammatory diseases. The data were presented in a late-breaking poster titled “The PARP14 Inhibitor RBN-3143 Suppresses Lung Inflammation in Preclinical Models
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ribon Therapeutics
Sign Up For FreeTo access detailed company insights
Ribon Therapeutics is a clinical stage biotechnology company developing therapeutics targeting novel enzyme families activated under cellular stress conditions that contribute to disease with the goal of developing effective treatments for patients with limited therapeutic options. Ribon Therapeutics is located in Cambridge, Massachusetts.... Read More
